Cargando…

Efficacy and Safety of Vernakalant for Cardioversion of Recent-onset Atrial Fibrillation in the Asia–Pacific Region: A Phase 3 Randomized Controlled Trial

Atrial fibrillation (AF) is a common clinically significant cardiac arrhythmia. This phase 3 randomized, double-blind, placebo-controlled trial assessed the efficacy and safety of vernakalant hydrochloride for the pharmacological conversion of AF to sinus rhythm in patients with recent-onset (>3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beatch, Gregory N., Bhirangi, Kiran, Juul-Moller, Steen, Rustige, Jörg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Journal of Cardiovascular Pharmacology 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295492/ https://www.ncbi.nlm.nih.gov/pubmed/27828791 http://dx.doi.org/10.1097/FJC.0000000000000445

Ejemplares similares

Vernakalant for Cardioversion of Recent-Onset Atrial Fibrillation in the Emergency Department: The SPECTRUM Study
por: Bager, Johan-Emil, et al.
Publicado: (2022)

Vernakalant for Rapid Cardioversion of Recent-Onset Atrial Fibrillation: Results from the SPECTRUM Study
por: Lévy, Samuel, et al.
Publicado: (2020)

Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update
por: Tsuji, Yukiomi, et al.
Publicado: (2013)

Efficacy and safety of vernakalant for cardioversion of recent-onset atrial fibrillation: A protocol for systematic review and meta-analysis
por: Li, Hong, et al.
Publicado: (2022)

Safety and efficacy of vernakalant for the conversion of atrial fibrillation to sinus rhythm; a phase 3b randomized controlled trial
por: Beatch, Gregory N., et al.
Publicado: (2016)

Vernakalant and electrical cardioversion for AF – Safe and effective
por: Simon, Alexander, et al.
Publicado: (2019)

Body Weight Counts—Cardioversion with Vernakalant or Ibutilide at the Emergency Department
por: Lindmayr, Teresa, et al.
Publicado: (2022)

Hemodynamic effects of Vernakalant in cardio-surgical ICU-patients treated for recent-onset postoperative atrial fibrillation
por: Schnaubelt, S., et al.
Publicado: (2020)

Meta-analysis of effect of vernakalant on conversion of atrial fibrillation
por: Yan, He, et al.
Publicado: (2013)

Suitability, Efficacy, and Safety of Vernakalant for New Onset Atrial Fibrillation in Critically Ill Patients
por: Rudiger, Alain, et al.
Publicado: (2014)

Vernakalant is superior to ibutilide for achieving sinus rhythm in patients with recent-onset atrial fibrillation: a randomized controlled trial at the emergency department()
por: Simon, Alexander, et al.
Publicado: (2017)

Recent-onset atrial fibrillation: a study exploring the elements of Virchow’s triad after cardioversion
por: Arvanitis, Panagiotis, et al.
Publicado: (2021)

Vernakalant in Atrial Fibrillation: A Relatively New Weapon in the Armamentarium Against an Old Enemy
por: Kossaify, Antoine
Publicado: (2019)

Incidence and Determinants of Spontaneous Cardioversion of Early Onset Symptomatic Atrial Fibrillation
por: Mariani, Marco Valerio, et al.
Publicado: (2022)

Cardioversion of atrial fibrillation does not affect obstructive sleep apnea
por: Höglund, Niklas, et al.
Publicado: (2017)

Pharmacological cardioversion for atrial fibrillation and flutter
por: Cordina, J, et al.
Publicado: (2006)

Atrial fibrillation cardioversion following acupuncture
por: Dilber, Dario, et al.
Publicado: (2015)

Rivaroxaban in atrial fibrillation cardioversion: an update
por: Lavalle, Carlo, et al.
Publicado: (2019)

How to Optimize Cardioversion of Atrial Fibrillation
por: Airaksinen, K. E. Juhani
Publicado: (2022)

A Cardioversion and Renal Dysfunction Cascade: Cardioversion for Atrial Fibrillation, Acute Kidney Injury, and Recurrence of Atrial Fibrillation
por: Asemota, Iriagbonse R, et al.
Publicado: (2020)

Pharmacological Cardioversion in Patients with Recent-Onset Atrial Fibrillation and Chronic Kidney Disease Subanalysis of the CANT II Study
por: Ceynowa-Sielawko, Beata, et al.
Publicado: (2022)

Current Status of Internal Cardioversion in Atrial Fibrillation
por: Plewan, Andreas, et al.
Publicado: (2002)

Ogilvie's Syndrome following Cardioversion for Atrial Fibrillation
por: Al-Halawani, Moh'd, et al.
Publicado: (2014)

Chemical Cardioversion of Atrial Fibrillation with Calcium Gluconate
por: Serhat, A, et al.
Publicado: (2012)

Timing of cardioversion in atrial fibrillation: the sooner the better?
por: Capranzano, Piera, et al.
Publicado: (2020)

Defining the benefit: Cardioversion of persistent atrial fibrillation
por: Nedios, Sotirios, et al.
Publicado: (2021)

Prediction of Successful Pharmacological Cardioversion in Acute Symptomatic Atrial Fibrillation: The Successful Intravenous Cardioversion for Atrial Fibrillation (SIC-AF) Score
por: Niederdöckl, Jan Daniel, et al.
Publicado: (2022)

Disappointing success of electrical cardioversion for new-onset atrial fibrillation in cardiosurgical ICU patients
por: Arrigo, M, et al.
Publicado: (2015)

Electric Cardioversion vs. Pharmacological with or without Electric Cardioversion for Stable New-Onset Atrial Fibrillation: A Systematic Review and Meta-Analysis
por: Prasai, Paritosh, et al.
Publicado: (2023)

Termination of Vernakalant-Resistant Atrial Fibrillation by Inhibition of Small-Conductance Ca(2+)-Activated K(+) Channels in Pigs
por: Diness, Jonas Goldin, et al.
Publicado: (2017)

Introducing Vernakalant into Clinical Practice
por: Hall, Angela JM, et al.
Publicado: (2019)

Role for machine learning in sex-specific prediction of successful electrical cardioversion in atrial fibrillation?
por: Vinter, Nicklas, et al.
Publicado: (2020)

The Role of Biphasic Shocks for Transthoracic Cardioversion of Atrial Fibrillation
por: Walsh, Simon J, et al.
Publicado: (2005)

Planning and monitoring of patients for electrical cardioversion for atrial fibrillation
por: Deuling, J. H. H., et al.
Publicado: (2011)

Comparison of monophasic versus biphasic cardioversion for atrial fibrillation
por: Vaisman, M, et al.
Publicado: (2005)

Rare Coronary Embolism Secondary to Cardioversion of Atrial Fibrillation
por: Alkhatib, Deya, et al.
Publicado: (2022)

QTc Dynamics Following Cardioversion for Persistent Atrial Fibrillation
por: Younis, Arwa, et al.
Publicado: (2022)

Transesophageal Echocardiogram Before Cardioversion in Atrial Fibrillation Patients
por: Adedara, Victor O, et al.
Publicado: (2023)

The Outcome of Electrical Cardioversion in Hyperthyroid Induced Atrial Fibrillation
por: Shah, Hriday, et al.
Publicado: (2023)

Effect of Early Pharmacologic Cardioversion vs. Non-early Cardioversion in the Patients With Recent-Onset Atrial Fibrillation Within 4-Week Follow-Up Period: A Systematic Review and Network Meta-Analysis
por: Tang, Yan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bkj1g1msl2321une0ed8sigo7i